All

Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma.  Boehringer Ingelheim today announced the acquisition of privately-held T3 Pharma…

Versameb AG, a leading pre-clinical stage biotechnology company, has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND)…

This first-in-human study evaluates the safety, tolerability and efficacy of ALE.C04 as a monotherapy and in combination.Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company within our portfolio…

Dr. Markus Kalousek takes on the role of Chairperson at FimmCyte, a pioneering women's health biotech, starting from 1 Nov 2023. With over 25 years in…

Onena Medicines closes 3.7M CHF funding round to advance its novel DSIP targeting antibody portfolio.Onena Medicines AG, a cellular reprogramming platform drug discovery company, announced…

We are delighted to announce that Johnson and Johnson is continuing its partnership with BaseLaunch to help support cutting-edge early-stage biotechs to achieve financing and…